ECS Botanics Holdings Ltd
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally. It is involved in the agriculture business. ECS Botanics Holdings Ltd is based in Murrabit, Australia.
Market Cap & Net Worth: ECS Botanics Holdings Ltd (ECS)
ECS Botanics Holdings Ltd (AU:ECS) has a market capitalization of $5.44 Million (AU$8.78 Million) as of March 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #33338 globally and #1146 in its home market, demonstrating a 10.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ECS Botanics Holdings Ltd's stock price AU$0.01 by its total outstanding shares 1596049567 (1.60 Billion).
ECS Botanics Holdings Ltd Market Cap History: 2015 to 2026
ECS Botanics Holdings Ltd's market capitalization history from 2015 to 2026. Data shows change from $86.57 Million to $5.44 Million (-23.34% CAGR).
ECS Botanics Holdings Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ECS Botanics Holdings Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.33x
ECS Botanics Holdings Ltd's market cap is 0.33 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $86.57 Million | $67.89K | -$351.29K | 1275.17x | N/A |
| 2017 | $86.57 Million | $350.00 | -$263.55K | 247345.76x | N/A |
| 2018 | $86.57 Million | $21.64K | -$218.71K | 4000.51x | N/A |
| 2019 | $48.42 Million | $836.76K | -$565.73K | 57.87x | N/A |
| 2020 | $38.54 Million | $836.76K | -$4.57 Million | 46.06x | N/A |
| 2021 | $30.64 Million | $1.25 Million | -$4.34 Million | 24.57x | N/A |
| 2022 | $19.77 Million | $5.30 Million | -$1.11 Million | 3.73x | N/A |
| 2023 | $22.24 Million | $15.39 Million | -$81.76K | 1.44x | N/A |
| 2024 | $16.80 Million | $20.03 Million | $1.92 Million | 0.84x | 8.77x |
| 2025 | $6.42 Million | $19.36 Million | -$5.73 Million | 0.33x | N/A |
Competitor Companies of ECS by Market Capitalization
Companies near ECS Botanics Holdings Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to ECS Botanics Holdings Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
ECS Botanics Holdings Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, ECS Botanics Holdings Ltd's market cap moved from $86.57 Million to $ 5.44 Million, with a yearly change of -23.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$5.44 Million | -15.38% |
| 2025 | AU$6.42 Million | -61.76% |
| 2024 | AU$16.80 Million | -24.44% |
| 2023 | AU$22.24 Million | +12.50% |
| 2022 | AU$19.77 Million | -35.48% |
| 2021 | AU$30.64 Million | -20.51% |
| 2020 | AU$38.54 Million | -20.41% |
| 2019 | AU$48.42 Million | -44.06% |
| 2018 | AU$86.57 Million | 0.00% |
| 2017 | AU$86.57 Million | 0.00% |
| 2016 | AU$86.57 Million | 0.00% |
| 2015 | AU$86.57 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ECS Botanics Holdings Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.44 Million USD |
| MoneyControl | $5.44 Million USD |
| MarketWatch | $5.44 Million USD |
| marketcap.company | $5.44 Million USD |
| Reuters | $5.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.